Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing

A.C.J.W. Janssens, P.A. Deverka

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)652-654
JournalClinical Pharmacology & Therapeutics
Volume96
Issue number6
DOIs
Publication statusPublished - 2014

Cite this

@article{f3e8c2c8c9024a239d944bb9775fe38d,
title = "Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing",
author = "A.C.J.W. Janssens and P.A. Deverka",
year = "2014",
doi = "10.1038/clpt.2014.186",
language = "Undefined/Unknown",
volume = "96",
pages = "652--654",
journal = "Clinical Pharmacology & Therapeutics",
issn = "0009-9236",
publisher = "Wiley-Blackwell",
number = "6",

}

Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing. / Janssens, A.C.J.W.; Deverka, P.A.

In: Clinical Pharmacology & Therapeutics, Vol. 96, No. 6, 2014, p. 652-654.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing

AU - Janssens, A.C.J.W.

AU - Deverka, P.A.

PY - 2014

Y1 - 2014

U2 - 10.1038/clpt.2014.186

DO - 10.1038/clpt.2014.186

M3 - Article

VL - 96

SP - 652

EP - 654

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

SN - 0009-9236

IS - 6

ER -